Patient with Advanced Skin Cancer in Remission for More than a Year Following Clinical Trial of WTX-124

Research holds promise for treating skin conditions

BAR HARBOR — The MDI Biological Laboratory has patented a way to inhibit melanin production, offering potential treatments for pigment-related skin conditions and at least one type of melanoma, a news release said.

Patient with advanced skin cancer in remission for more than a year following clinical trial of WTX-124

A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new targeted immune-therapy in a clinical trial at HonorHealth Research Institute.

Rita Daniela Fulfills Promise To Mom After She Passed Cancer Remission Stage

Kapuso actress Rita Daniela fulfilled her long-held promise to her mother. On Instagram, Rita Daniela shared heartwarming photos with her mother as the latter passed the remission stage of cancer. In 2019, the mother of Kapuso actress Rita Daniela was diagnosed with breast cancer. As much as we all know, this condition and diagnosis are ... Read more The post Rita Daniela Fulfills Promise To Mom After She Passed Cancer Remission Stage appeared f…

HonorHealth Research Institute Patient with Advanced Skin Cancer Achieves

In a remarkable advance in cancer immunotherapy, a novel targeted immune treatment has brought lasting remission to a patient suffering from cutaneous squamous cell carcinoma (cSCC), a common yet disfiguring form of skin cancer with a risk of lethality when untreated. This breakthrough was achieved through an innovative clinical trial conducted at the HonorHealth Research Institute in Scottsdale, Arizona, a leading center focused on pioneering c…